Novo sues Eli on ads

China's drug regulator accepts Novo Nordisk's application for oral Wegovy

Novo Nordisk confirmed China's drug regulator accepted its application for an oral version of Wegovy, joining competitors like Eli Lilly in the expanding Chinese weight-loss market. Analysts project G